As of Mar 03
| +0.0501 / +1.42%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,014.18% increase from the last price of 3.59.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.